236 related articles for article (PubMed ID: 20711297)
1. Stevens-Johnson syndrome-toxic epidermal necrolysis (SJS-TEN) overlap associated with carbamazepine use.
Suresh Kumar PN; Thomas B; Kumar K; Kumar S
Indian J Psychiatry; 2005 Apr; 47(2):121-3. PubMed ID: 20711297
[TBL] [Abstract][Full Text] [Related]
2. Can vitamin B-complex aggravate the carbamazepine induced toxic epidermal necrolysis?
Fegade MV; Bhounsule SA; Pereira I
J Clin Diagn Res; 2012 Nov; 6(9):1571-3. PubMed ID: 23285463
[TBL] [Abstract][Full Text] [Related]
3. Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Treated Successfully with Oral Cyclosporin: Case report and literature review.
Al Rajaibi R; Al Rumhi T; Al Abri AM
Sultan Qaboos Univ Med J; 2021 Aug; 21(3):491-494. PubMed ID: 34522420
[TBL] [Abstract][Full Text] [Related]
4. Stevens-Johnson syndrome progressing to toxic epidermal necrolysis with haloperidol and carbamazepine combination.
Kumar A; Sarkar S; Praharaj SK; Akhtar S; Diwakar M
Ind Psychiatry J; 2011 Jul; 20(2):131-3. PubMed ID: 23271869
[TBL] [Abstract][Full Text] [Related]
5. Investigation of Monnose-Binding Lectin gene Polymorphism in Patients with Erythema Multiforme, Stevens-Johnson Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Syndrome.
Karkucak M; Bülbül EB; Turan H; Yakut T; Toka S; Sarıcaoğlu H
Balkan Med J; 2012 Sep; 29(3):310-3. PubMed ID: 25207021
[TBL] [Abstract][Full Text] [Related]
6. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
[TBL] [Abstract][Full Text] [Related]
7. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
Hasegawa A; Abe R
F1000Res; 2020; 9():. PubMed ID: 32595945
[TBL] [Abstract][Full Text] [Related]
9. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
Tan SK; Tay YK
Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
[TBL] [Abstract][Full Text] [Related]
10. [Stevens-Johnson syndrome with transition to toxic epidermal necrolysis after carbamazepine administration, heroin and alcohol abuse].
Petter G; Haustein UF
Hautarzt; 1999 Dec; 50(12):884-8. PubMed ID: 10663024
[TBL] [Abstract][Full Text] [Related]
11. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].
Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN
Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
[TBL] [Abstract][Full Text] [Related]
13. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
Gleghorn KL; Voigt C; Kelly B
Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
[TBL] [Abstract][Full Text] [Related]
14. Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013.
Suwarsa O; Yuwita W; Dharmadji HP; Sutedja E
Asia Pac Allergy; 2016 Jan; 6(1):43-7. PubMed ID: 26844219
[TBL] [Abstract][Full Text] [Related]
15. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
16. Carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a Filipino with positive HLA-B75 serotype.
Capule F; Tragulpiankit P; Mahasirimongkol S; Wichukchinda N; Jittikoon J; Alentajan-Aleta LT; James Barit JV; Casanova-Gutierrez J; Cabral-Lim L; Baltazar Reyes JP; Roa F; San Gabriel KF; Silao CL
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30018035
[TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
Schneider JA; Cohen PR
Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
[TBL] [Abstract][Full Text] [Related]
18. Causative Drugs and Clinical Outcome in Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and SJS-TEN Overlap in Children.
Sethuraman G; Sharma VK; Pahwa P; Khetan P
Indian J Dermatol; 2012 May; 57(3):199-200. PubMed ID: 22707771
[TBL] [Abstract][Full Text] [Related]
19. Drug-related Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review.
Arora R; Pande RK; Panwar S; Gupta V
Indian J Crit Care Med; 2021 May; 25(5):575-579. PubMed ID: 34177178
[TBL] [Abstract][Full Text] [Related]
20. Critical factors differentiating erythema multiforme majus from Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN).
Watanabe R; Watanabe H; Sotozono C; Kokaze A; Iijima M
Eur J Dermatol; 2011; 21(6):889-94. PubMed ID: 21873140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
